Skip to main content
TipRanks
Go Ultimate75% OFF

SAB Biotherapeutics (SABS) Revenue

329 Followers

SAB Biotherapeutics Revenue

Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
―
Revenue/Employee
$0
Employees
86
Market Cap
$276.57M

Revenue Chart

SAB Biotherapeutics Revenue - Annual

010M20M30M40M50M60M70M3.44M55.24M60.88M23.90M2.24M1.32M2019202020212023202320252025
Revenue History
Download to Excel
SABS revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20250.00-1.32M-100.00%
Mar 31, 20251.32M-916.59K-40.94%
Dec 31, 20232.24M-21.66M-90.63%
Mar 31, 202323.90M-36.97M-60.73%
Dec 31, 202160.88M5.64M10.21%
Dec 31, 202055.24M51.80M1504.82%
Dec 31, 20193.44M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
SABS0.00
LSTA100.00K
NXTC0.00
RLYB434.00K